Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components
Authors
Keywords
-
Journal
Diabetology & Metabolic Syndrome
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-30
DOI
10.1186/s13098-017-0241-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diet low in advanced glycation end products increases insulin sensitivity in healthy overweight individuals: a double-blind, randomized, crossover trial
- (2016) Barbora de Courten et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study
- (2016) Fritz-Line Vélayoudom-Céphise et al. Cardiovascular Diabetology
- Lifestyle and clinical determinants of skin autofluorescence in a population-based cohort study
- (2016) Robert P. van Waateringe et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Skin Autofluorescence and Pentosidine Are Associated With Aortic StiffeningNovelty and Significance
- (2016) Marcelle G.A. van Eupen et al. HYPERTENSION
- Dietary consumption of advanced glycation end products and risk of metabolic syndrome
- (2016) Pooneh Angoorani et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Increased skin autofluorescence of children and adolescents with type 1 diabetes despite a well-controlled HbA1c: results from a cohort study
- (2016) Josine C. van der Heyden et al. BMC Endocrine Disorders
- How HDL protects LDL against atherogenic modification
- (2015) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- Advanced glycation end-products: modifiable environmental factors profoundly mediate insulin resistance
- (2015) Mona S. Ottum et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- Elevated Serum Advanced Glycation Endproducts in Obese Indicate Risk for the Metabolic Syndrome: A Link Between Healthy and Unhealthy Obesity?
- (2015) Jaime Uribarri et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Prevalence of Overweight and Obesity in the United States, 2007-2012
- (2015) Lin Yang et al. JAMA Internal Medicine
- Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study
- (2015) Tom Teichert et al. PLoS One
- Cohort Profile: LifeLines, a three-generation cohort study and biobank
- (2014) Salome Scholtens et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Skin Autofluorescence Predicts Cardiovascular Mortality in Patients on Chronic Hemodialysis
- (2014) Hiroshi Kimura et al. THERAPEUTIC APHERESIS AND DIALYSIS
- The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies
- (2014) Jana V van Vliet-Ostaptchouk et al. BMC Endocrine Disorders
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Advanced glycation endproducts and its receptor for advanced glycation endproducts in obesity
- (2013) Katrien HJ. Gaens et al. CURRENT OPINION IN LIPIDOLOGY
- Consumption of a Diet Low in Advanced Glycation End Products for 4 Weeks Improves Insulin Sensitivity in Overweight Women
- (2013) Alicja Budek Mark et al. DIABETES CARE
- Skin Autofluorescence, a Non-Invasive Marker for AGE Accumulation, Is Associated with the Degree of Atherosclerosis
- (2013) Martijn A. M. den Dekker et al. PLoS One
- Skin Autofluorescence as a Measure of Advanced Glycation End Products Deposition Is Elevated in Peripheral Artery Disease
- (2012) Lisanne C. de Vos et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Skin autofluorescence is inversely related to HDL anti-oxidative capacity in type 2 diabetes mellitus
- (2011) Douwe J. Mulder et al. ATHEROSCLEROSIS
- Restriction of Advanced Glycation End Products Improves Insulin Resistance in Human Type 2 Diabetes: Potential role of AGER1 and SIRT1
- (2011) J. Uribarri et al. DIABETES CARE
- Skin autofluorescence is associated with severity of vascular complications in Japanese patients with Type 2 diabetes
- (2011) K. Tanaka et al. DIABETIC MEDICINE
- Advanced glycation end products (AGEs) in relation to atherosclerotic lipid profiles in middle-aged and elderly diabetic patients
- (2011) Jin-Biou Chang et al. Lipids in Health and Disease
- Age and Sex Differences in the Clustering of Metabolic Syndrome Factors: Association with mortality risk
- (2010) J. L. Kuk et al. DIABETES CARE
- Reference Values of Skin Autofluorescence
- (2010) M. Koetsier et al. Diabetes Technology & Therapeutics
- Advanced Glycation End Products in Foods and a Practical Guide to Their Reduction in the Diet
- (2010) Jaime Uribarri et al. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
- Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products
- (2007) Douwe J. Mulder et al. ATHEROSCLEROSIS
- Skin autofluorescence in type 2 diabetes: Beyond blood glucose
- (2007) Matteo Monami et al. DIABETES RESEARCH AND CLINICAL PRACTICE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search